{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:46:54Z","timestamp":1787982414318,"version":"build-2784847793"},"reference-count":197,"publisher":"Aging and Disease","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging and disease"],"published-print":{"date-parts":[[2025]]},"DOI":"10.14336\/ad.2024.0328","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T10:51:22Z","timestamp":1712227882000},"page":"841","source":"Crossref","is-referenced-by-count":15,"title":["Role of Serotonylation and SERT Posttranslational Modifications in Alzheimer's Disease Pathogenesis"],"prefix":"10.14336","volume":"16","author":[{"given":"Arubala P.","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Rawat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Rohr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razelle","family":"Alvir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasbir","family":"Bisht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mst Anika","family":"Bushra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Luong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aananya P.","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5462","reference":[{"key":"key-10.14336\/AD.2024.0328-1","doi-asserted-by":"crossref","unstructured":"Wang Y-C, Peterson SE, Loring JF (2014). Protein post-translational modifications and regulation of pluripotency in human stem cells. Cell res, 24: 143-160","DOI":"10.1038\/cr.2013.151"},{"key":"key-10.14336\/AD.2024.0328-2","doi-asserted-by":"crossref","unstructured":"Blom N, Sicheritz-Pont\u00e9n T, Gupta R, Gammeltoft S, Brunak S (2004). Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence. Proteomics, 4: 1633-1649","DOI":"10.1002\/pmic.200300771"},{"key":"key-10.14336\/AD.2024.0328-3","doi-asserted-by":"crossref","unstructured":"Hummerich R, Schloss P (2010). Serotonin\u2014more than a neurotransmitter: transglutaminase-mediated serotonylation of C6 glioma cells and fibronectin. Neurochem Int, 57: 67-75","DOI":"10.1016\/j.neuint.2010.04.020"},{"key":"key-10.14336\/AD.2024.0328-4","doi-asserted-by":"crossref","unstructured":"Ivashkin E, Melnikova V, Kurtova A, Brun NR, Obukhova A, Khabarova MY, et al. (2019). Transglutaminase activity determines nuclear localization of serotonin immunoreactivity in the early embryos of invertebrates and vertebrates. ACS Chem Neurosci, 10: 3888-3899","DOI":"10.1021\/acschemneuro.9b00346"},{"key":"key-10.14336\/AD.2024.0328-5","doi-asserted-by":"crossref","unstructured":"Sahu A, Gopalakrishnan L, Gaur N, Chatterjee O, Mol P, Modi PK, et al. (2018). The 5-Hydroxytryptamine signaling map: an overview of serotonin-serotonin receptor mediated signaling network. J Cell Commun Signal, 12: 731-735","DOI":"10.1007\/s12079-018-0482-2"},{"key":"key-10.14336\/AD.2024.0328-6","doi-asserted-by":"crossref","unstructured":"Jenkins TA, Nguyen JC, Polglaze KE, Bertrand PP (2016). Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain axis. Nutrients, 8: 56","DOI":"10.3390\/nu8010056"},{"key":"key-10.14336\/AD.2024.0328-7","doi-asserted-by":"crossref","unstructured":"Walther DJ, Peter J-U, Winter S, H\u00f6ltje M, Paulmann N, Grohmann M, et al. (2003). Serotonylation of small GTPases is a signal transduction pathway that triggers platelet \u03b1-granule release. Cell, 115: 851-862","DOI":"10.1016\/S0092-8674(03)01014-6"},{"key":"key-10.14336\/AD.2024.0328-8","doi-asserted-by":"crossref","unstructured":"Hummerich R, Thumfart J-O, Findeisen P, Bartsch D, Schloss P (2012). Transglutaminase-mediated transamidation of serotonin, dopamine and noradrenaline to fibronectin: Evidence for a general mechanism of monoaminylation. FEBS Lett, 586: 3421-3428","DOI":"10.1016\/j.febslet.2012.07.062"},{"key":"key-10.14336\/AD.2024.0328-9","doi-asserted-by":"crossref","unstructured":"Lewis GP. 1958. 5-hydroxytryptamine: Pergamon Press London","DOI":"10.1111\/j.2042-7158.1958.tb10338.x"},{"key":"key-10.14336\/AD.2024.0328-10","unstructured":"Small SA (1988). Vasoactivity of the coronary artery in Salmo gairdneri"},{"key":"key-10.14336\/AD.2024.0328-11","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Mu\u00f1oz F, Alamo C (2009). Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today. Curr Pharm Des, 15: 1563-1586","DOI":"10.2174\/138161209788168001"},{"key":"key-10.14336\/AD.2024.0328-12","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Mu\u00f1oz F, \u00c1lamo C (2016). History of the discovery of antidepressant drugs. Melatonin, Neuroprotective Agents and Antidepressant Therapy, 365-383","DOI":"10.1007\/978-81-322-2803-5_26"},{"key":"key-10.14336\/AD.2024.0328-13","doi-asserted-by":"crossref","unstructured":"Kline NS (2022). Commentary on Clinical discoveries with antidepressant drugs by Heinz E. Lehmann and. Discoveries in Pharmacology-Volume 1-Nervous System and Hormones, 117","DOI":"10.1016\/B978-0-323-85519-8.00002-X"},{"key":"key-10.14336\/AD.2024.0328-14","doi-asserted-by":"crossref","unstructured":"Mulinari S (2012). Monoamine theories of depression: historical impact on biomedical research. J Hist Neurosci, 21: 366-392","DOI":"10.1080\/0964704X.2011.623917"},{"key":"key-10.14336\/AD.2024.0328-15","doi-asserted-by":"crossref","unstructured":"Hindmarch I (2001). Expanding the horizons of depression: beyond the monoamine hypothesis. Hum Psychopharmacol, 16: 203-218","DOI":"10.1002\/hup.288"},{"key":"key-10.14336\/AD.2024.0328-16","unstructured":"Hirschfeld RM (2000). History and evolution of the monoamine hypothesis of depression. J Clin Psychiatry, 61: 4-6"},{"key":"key-10.14336\/AD.2024.0328-17","unstructured":"Nair N, Sharma M (1989). Neurochemical and receptor theories of depression. Psychiatric Psychiatr J Univ Ott, 14: 328-341."},{"key":"key-10.14336\/AD.2024.0328-18","doi-asserted-by":"crossref","unstructured":"Kerwin RW (1990). Monoamine oxidase inhibitors: 30 years of progress? International Rev of Psychiatr, 2: 179-185","DOI":"10.3109\/09540269009028281"},{"key":"key-10.14336\/AD.2024.0328-19","unstructured":"Thase ME (2012). The role of monoamine oxidase inhibitors in depression treatment guidelines. The Primary Care Companion for CNS Disorders, 14: 27265"},{"key":"key-10.14336\/AD.2024.0328-20","doi-asserted-by":"crossref","unstructured":"Mitsuhashi S, Kojima T, Nakanishi N, Fujimoto T, Goto O, Miyusaki S, et al. (1992). The new generation of monoamine oxidase inhibitors. Prog Drug Res, 171-297","DOI":"10.1007\/978-3-0348-7141-9_3"},{"key":"key-10.14336\/AD.2024.0328-21","unstructured":"Barondes SH. 2003. Better than Prozac: Creating the next generation of psychiatric drugs: Discov Med"},{"key":"key-10.14336\/AD.2024.0328-22","doi-asserted-by":"crossref","unstructured":"Fagius J, Osterman P, Siden A, Wiholm B (1985). Guillain-Barr\u00e9 syndrome following zimeldine treatment. J Neurol Neurosurg Psychiatry, 48: 65-69","DOI":"10.1136\/jnnp.48.1.65"},{"key":"key-10.14336\/AD.2024.0328-23","doi-asserted-by":"crossref","unstructured":"Lee C-W, Chen Y-J, Wu H-F, Chung Y-J, Lee Y-C, Li C-T, et al. (2019). Ketamine ameliorates severe traumatic event-induced antidepressant-resistant depression in a rat model through ERK activation. Prog Neuropsychopharmacol Biol Psychiatry, 93: 102-113","DOI":"10.1016\/j.pnpbp.2019.03.015"},{"key":"key-10.14336\/AD.2024.0328-24","unstructured":"Han EH, Kim H, Lee KJ (2020). Comparison of Effect of SSRIs and SNRIs on Depression, Pain and Somatic Symptoms in Elderly Patients with Major Depressive Disorder. Korean J. Psychom. Med, 28: 72-80"},{"key":"key-10.14336\/AD.2024.0328-25","doi-asserted-by":"crossref","unstructured":"Vismara M, Benatti B, Nicolini G, Cova I, Monfrini E, Di Fonzo A, et al. (2022). Clinical uses of Bupropion in patients with Parkinson\u2019s disease and comorbid depressive or neuropsychiatric symptoms: a scoping review. BMC Neurol, 22: 169","DOI":"10.1186\/s12883-022-02668-4"},{"key":"key-10.14336\/AD.2024.0328-26","doi-asserted-by":"crossref","unstructured":"Anttila SA, Leinonen EV (2001). A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev, 7: 249-264","DOI":"10.1111\/j.1527-3458.2001.tb00198.x"},{"key":"key-10.14336\/AD.2024.0328-27","doi-asserted-by":"crossref","unstructured":"Benkert O, Muller M, Szegedi A (2002). An overview of the clinical efficacy of mirtazapine. Hum Psychopharmacol, 17: S23-S26","DOI":"10.1002\/hup.397"},{"key":"key-10.14336\/AD.2024.0328-28","doi-asserted-by":"crossref","unstructured":"Reynolds CFIII, Frank E, Perel JM, Mazumdar S, Kupfer DJ (1995). Maintenance therapies for late-life recurrent major depression: research and review circa 1995. Int Psychogeriatr, 7: 27-39","DOI":"10.1017\/S104161029500233X"},{"key":"key-10.14336\/AD.2024.0328-29","doi-asserted-by":"crossref","unstructured":"Stewart RB, Marks RG, Padgett PD, Hale WE (1994). Antidepressant drug use in an ambulatory elderly population: A 14-year overview. Pharmacoepidemiology and Drug Safety, 3:23-29","DOI":"10.1002\/pds.2630030107"},{"key":"key-10.14336\/AD.2024.0328-30","doi-asserted-by":"crossref","unstructured":"Paykel ES (2000). Antidepressants in the 1990s. Epidemiol Psichiatr Soc, 9: 152-155","DOI":"10.1017\/S1121189X00007831"},{"key":"key-10.14336\/AD.2024.0328-31","doi-asserted-by":"crossref","unstructured":"Hillhouse TM, Porter JH (2015). A brief history of the development of antidepressant drugs: from monoamines to glutamate. Exp Clin Psychopharmacol, 23: 1","DOI":"10.1037\/a0038550"},{"key":"key-10.14336\/AD.2024.0328-32","doi-asserted-by":"crossref","unstructured":"Pereira VS, Hiroaki-Sato VA (2018). A brief history of antidepressant drug development: from tricyclics to beyond ketamine. Acta Neuropsychiatr, 30: 307-322","DOI":"10.1017\/neu.2017.39"},{"key":"key-10.14336\/AD.2024.0328-33","doi-asserted-by":"crossref","unstructured":"Schatzberg AF (1998). Noradrenergic versus serotonergic antidepressants: predictors of treatment response. J Clin Psychiatry, 59: 15-18","DOI":"10.4088\/JCP.v59n1007b"},{"key":"key-10.14336\/AD.2024.0328-34","doi-asserted-by":"crossref","unstructured":"Anthony J, Sexton T, Neumaier J (2000). Antidepressant-induced regulation of 5-HT1b mRNA in rat dorsal raphe nucleus reverses rapidly after drug discontinuation. J Neurosci Res, 61: 82-87","DOI":"10.1002\/1097-4547(20000701)61:1<82::AID-JNR10>3.0.CO;2-E"},{"key":"key-10.14336\/AD.2024.0328-35","doi-asserted-by":"crossref","unstructured":"Baghai TC, Volz H-P, M\u00f6ller H-J (2006). Drug treatment of depression in the 2000s: An overview of achievements in the last 10 years and future possibilities. World J Biol Psychiatry, 7: 198-222","DOI":"10.1080\/15622970601003973"},{"key":"key-10.14336\/AD.2024.0328-36","doi-asserted-by":"crossref","unstructured":"Kim SW, Park SY, Hwang O (2002). Up-regulation of tryptophan hydroxylase expression and serotonin synthesis by sertraline. Mol Pharmacol, 61: 778-785","DOI":"10.1124\/mol.61.4.778"},{"key":"key-10.14336\/AD.2024.0328-37","doi-asserted-by":"crossref","unstructured":"Huang Y-J, Lane H-Y, Lin C-H (2017). New treatment strategies of depression: based on mechanisms related to neuroplasticity. Neural Plast","DOI":"10.1155\/2017\/4605971"},{"key":"key-10.14336\/AD.2024.0328-38","doi-asserted-by":"crossref","unstructured":"Mdawar B, Ghossoub E, Khoury R (2020). Selective serotonin reuptake inhibitors and Alzheimer\u2019s disease. Neural Regen Res, 15: 41","DOI":"10.4103\/1673-5374.264445"},{"key":"key-10.14336\/AD.2024.0328-39","doi-asserted-by":"crossref","unstructured":"Kl\u00f6bl M, Seiger R, Vanicek T, Handschuh P, Reed MB, Spurny-Dworak B, et al. (2022). Escitalopram modulates learning content-specific neuroplasticity of functional brain networks. Neuroimage, 247: 118829","DOI":"10.1016\/j.neuroimage.2021.118829"},{"key":"key-10.14336\/AD.2024.0328-40","doi-asserted-by":"crossref","unstructured":"Brodal A (1963). The reticular formation of the brain stem. Oliver and Boyd. Edinburgh, 1956. 5) Cajal, SR: Histologie du Systeme Nerveux de 1'Homme et des Vertebras Madrid, 1911. 6) Eyzaguirre, C. and Taylor, JR: Respiratory discharge of some vagal motoneurons. [J]. Neurophysiol, 26: x78","DOI":"10.1152\/jn.1963.26.1.61"},{"key":"key-10.14336\/AD.2024.0328-41","doi-asserted-by":"crossref","unstructured":"Hirano A, Iida M (2006). Topographic study of Alzheimer's neurofibrillary changes: a personal perspective. J Alzheimers Dis, 9: 53-60","DOI":"10.3233\/JAD-2006-9S307"},{"key":"key-10.14336\/AD.2024.0328-42","doi-asserted-by":"crossref","unstructured":"Rossor M (1981). Parkinson's disease and Alzheimer's disease as disorders of the isodendritic core. Br Med J (Clin Res Ed), 283: 1588","DOI":"10.1136\/bmj.283.6306.1588"},{"key":"key-10.14336\/AD.2024.0328-43","doi-asserted-by":"crossref","unstructured":"Benton JS, Bowen D, Allen S, Haan E, Davison A, Neary D, et al. (1982). Alzheimer's disease as a disorder of isodendritic core. Lancet, 319: 456","DOI":"10.1016\/S0140-6736(82)91667-1"},{"key":"key-10.14336\/AD.2024.0328-44","doi-asserted-by":"crossref","unstructured":"Mann DM (1991). Is the pattern of nerve cell loss in ageing and Alzheimer's disease a real, or only an apparent, selectivity? Neurobiol Aging, 12: 340-343","DOI":"10.1016\/0197-4580(91)90015-C"},{"key":"key-10.14336\/AD.2024.0328-45","doi-asserted-by":"crossref","unstructured":"Michelsen KA, Prickaerts J, Steinbusch HW (2008). The dorsal raphe nucleus and serotonin: implications for neuroplasticity linked to major depression and Alzheimer's disease. Prog Brain Res, 172: 233-264","DOI":"10.1016\/S0079-6123(08)00912-6"},{"key":"key-10.14336\/AD.2024.0328-46","doi-asserted-by":"crossref","unstructured":"Muma NA, Mi Z (2015). Serotonylation and transamidation of other monoamines. ACS Chem Neurosci, 6: 961-969","DOI":"10.1021\/cn500329r"},{"key":"key-10.14336\/AD.2024.0328-47","doi-asserted-by":"crossref","unstructured":"Walther DJ, Stahlberg S, Vowinckel J (2011). Novel roles for biogenic monoamines: from monoamines in transglutaminase-mediated post-translational protein modification to monoaminylation deregulation diseases. FEBS J, 278: 4740-4755","DOI":"10.1111\/j.1742-4658.2011.08347.x"},{"key":"key-10.14336\/AD.2024.0328-48","doi-asserted-by":"crossref","unstructured":"Dale GL, Friese P, Batar P, Hamilton SF, Reed GL, Jackson KW, et al. (2002). Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature, 415: 175-179","DOI":"10.1038\/415175a"},{"key":"key-10.14336\/AD.2024.0328-49","doi-asserted-by":"crossref","unstructured":"Dale G (2005). Coated-platelets: an emerging component of the procoagulant response. J Thromb Haemost, 3: 2185-2192","DOI":"10.1111\/j.1538-7836.2005.01274.x"},{"key":"key-10.14336\/AD.2024.0328-50","doi-asserted-by":"crossref","unstructured":"Farrelly LA, Thompson RE, Zhao S, Lepack AE, Lyu Y, Bhanu NV, et al. (2019). Histone serotonylation is a permissive modification that enhances TFIID binding to H3K4me3. Nature, 567: 535-539","DOI":"10.1038\/s41586-019-1024-7"},{"key":"key-10.14336\/AD.2024.0328-51","doi-asserted-by":"crossref","unstructured":"Paulmann N, Grohmann M, Voigt J-P, Bert B, Vowinckel J, Bader M, et al. (2009). Intracellular serotonin modulates insulin secretion from pancreatic \u03b2-cells by protein serotonylation. PLoS Biol, 7: e1000229","DOI":"10.1371\/journal.pbio.1000229"},{"key":"key-10.14336\/AD.2024.0328-52","doi-asserted-by":"crossref","unstructured":"Sakowski SA, Geddes TJ, Thomas DM, Levi E, Hatfield JS, Kuhn DM (2006). Differential tissue distribution of tryptophan hydroxylase isoforms 1 and 2 as revealed with monospecific antibodies. Brain Res, 1085: 11-18","DOI":"10.1016\/j.brainres.2006.02.047"},{"key":"key-10.14336\/AD.2024.0328-53","doi-asserted-by":"crossref","unstructured":"Walther DJ, Peter J-U, Bashammakh S, H\u00f6rtnagl H, Voits M, Fink H, et al. (2003). Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science, 299: 76-76","DOI":"10.1126\/science.1078197"},{"key":"key-10.14336\/AD.2024.0328-54","doi-asserted-by":"crossref","unstructured":"Fidalgo S, Ivanov DK, Wood SH (2013). Serotonin: from top to bottom. Biogerontology, 14: 21-45","DOI":"10.1007\/s10522-012-9406-3"},{"key":"key-10.14336\/AD.2024.0328-55","doi-asserted-by":"crossref","unstructured":"Moon JH, Oh CM, Kim H (2022). Serotonin in the regulation of systemic energy metabolism. J Diabetes Investig, 13: 1639-1645","DOI":"10.1111\/jdi.13879"},{"key":"key-10.14336\/AD.2024.0328-56","doi-asserted-by":"crossref","unstructured":"Kanova M, Kohout P (2021). Tryptophan: a unique role in the critically ill. Int J Mol Sci, 22: 11714","DOI":"10.3390\/ijms222111714"},{"key":"key-10.14336\/AD.2024.0328-57","doi-asserted-by":"crossref","unstructured":"Rudnick G, Sandtner W (2019). Serotonin transport in the 21st century. J Gen Physiol, 151: 1248-1264","DOI":"10.1085\/jgp.201812066"},{"key":"key-10.14336\/AD.2024.0328-58","doi-asserted-by":"crossref","unstructured":"Berger M, Gray JA, Roth BL (2009). The expanded biology of serotonin. Annu Rev Med, 60: 355-366","DOI":"10.1146\/annurev.med.60.042307.110802"},{"key":"key-10.14336\/AD.2024.0328-59","doi-asserted-by":"crossref","unstructured":"Bortolato M, Chen K, Shih JC (2010). The degradation of serotonin: role of MAO. Handb Behav Neurosci, 21:203-218","DOI":"10.1016\/S1569-7339(10)70079-5"},{"key":"key-10.14336\/AD.2024.0328-60","doi-asserted-by":"crossref","unstructured":"Prah A, Purg M, Stare J, Vianello R, Mavri J (2020). How monoamine oxidase A decomposes serotonin: an empirical valence bond simulation of the reactive step. J Phys Chem B, 124: 8259-8265","DOI":"10.1021\/acs.jpcb.0c06502"},{"key":"key-10.14336\/AD.2024.0328-61","doi-asserted-by":"crossref","unstructured":"Song W, Lahiri DK (1997). Melatonin alters the metabolism of the \u03b2-amyloid precursor protein in the neuroendocrine cell line PC12. J Mol Neurosci, 9: 75-92","DOI":"10.1007\/BF02736852"},{"key":"key-10.14336\/AD.2024.0328-62","doi-asserted-by":"crossref","unstructured":"Lahiri DK, Chen D, Ge YW, Bondy SC, Sharman EH (2004). Dietary supplementation with melatonin reduces levels of amyloid beta-peptides in the murine cerebral cortex. J Pineal Res, 36: 224-231","DOI":"10.1111\/j.1600-079X.2004.00121.x"},{"key":"key-10.14336\/AD.2024.0328-63","doi-asserted-by":"crossref","unstructured":"Mazda T, Yamamoto H, Fujimura M, Fujimiya M (2004). Gastric distension-induced release of 5-HT stimulates c-fos expression in specific brain nuclei via 5-HT3 receptors in conscious rats. Am J Physiol Gastrointest Liver Physiol, 287: G228-G235","DOI":"10.1152\/ajpgi.00373.2003"},{"key":"key-10.14336\/AD.2024.0328-64","doi-asserted-by":"crossref","unstructured":"Yabut JM, Crane JD, Green AE, Keating DJ, Khan WI, Steinberg GR (2019). Emerging roles for serotonin in regulating metabolism: new implications for an ancient molecule. Endocr Rev, 40: 1092-1107","DOI":"10.1210\/er.2018-00283"},{"key":"key-10.14336\/AD.2024.0328-65","doi-asserted-by":"crossref","unstructured":"Qin H-y, Luo J-l, Xu H-x, Sung JJ, Bian Z-x (2010). Visceral hypersensitivity induced by activation of transient receptor potential vanilloid type 1 is mediated through the serotonin pathway in rat colon. Eur J Pharmacol, 647: 75-83","DOI":"10.1016\/j.ejphar.2010.08.019"},{"key":"key-10.14336\/AD.2024.0328-66","doi-asserted-by":"crossref","unstructured":"Hoffman JM, Tyler K, MacEachern SJ, Balemba OB, Johnson AC, Brooks EM, et al. (2012). Activation of colonic mucosal 5-HT4 receptors accelerates propulsive motility and inhibits visceral hypersensitivity. Gastroenterology, 142: 844-854.e844","DOI":"10.1053\/j.gastro.2011.12.041"},{"key":"key-10.14336\/AD.2024.0328-67","doi-asserted-by":"crossref","unstructured":"Cenac N, Altier C, Motta J-P, d'Aldebert E, Galeano S, Zamponi GW, et al. (2010). Potentiation of TRPV4 signalling by histamine and serotonin: an important mechanism for visceral hypersensitivity. Gut, 59: 481","DOI":"10.1136\/gut.2009.192567"},{"key":"key-10.14336\/AD.2024.0328-68","doi-asserted-by":"crossref","unstructured":"Liu H-N, Ohya S, Nishizawa Y, Sawamura K, Iino S, Syed MM, et al. (2011). Serotonin augments gut pacemaker activity via 5-HT3 receptors. PLoS One, 6: e24928","DOI":"10.1371\/journal.pone.0024928"},{"key":"key-10.14336\/AD.2024.0328-69","doi-asserted-by":"crossref","unstructured":"Hansen MB, Witte AB (2008). The role of serotonin in intestinal luminal sensing and secretion. Acta Physiol (Oxf), 193: 311-323","DOI":"10.1111\/j.1748-1716.2008.01870.x"},{"key":"key-10.14336\/AD.2024.0328-70","doi-asserted-by":"crossref","unstructured":"Chen VC-H, Ng M-H, Chiu W-C, McIntyre RS, Lee Y, Lin T-Y, et al. (2017). Effects of selective serotonin reuptake inhibitors on glaucoma: A nationwide population-based study. PLoS One, 12: e0173005","DOI":"10.1371\/journal.pone.0173005"},{"key":"key-10.14336\/AD.2024.0328-71","doi-asserted-by":"crossref","unstructured":"Neumann J, Hofmann B, Dhein S, Gergs U (2023). Cardiac roles of serotonin (5-HT) and 5-HT-receptors in health and disease. Int J Mol Sci, 24: 4765","DOI":"10.3390\/ijms24054765"},{"key":"key-10.14336\/AD.2024.0328-72","doi-asserted-by":"crossref","unstructured":"Halperin D, Reber G (2007). Influence of antidepressants on hemostasis. Dialogues Clin Neurosci, 9: 47-59","DOI":"10.31887\/DCNS.2007.9.1\/dhalperin"},{"key":"key-10.14336\/AD.2024.0328-73","doi-asserted-by":"crossref","unstructured":"Jiang S-H, Wang Y-H, Hu L-P, Wang X, Li J, Zhang X-L, et al. (2021). The physiology, pathology and potential therapeutic application of serotonylation. J Cell Sci, 134: jcs257337","DOI":"10.1242\/jcs.257337"},{"key":"key-10.14336\/AD.2024.0328-74","doi-asserted-by":"crossref","unstructured":"Hayden EP, Dougherty LR, Maloney B, Olino TM, Sheikh H, Durbin CE, et al. (2008). Early-emerging cognitive vulnerability to depression and the serotonin transporter promoter region polymorphism. J Affect Disord, 107: 227-230","DOI":"10.1016\/j.jad.2007.07.028"},{"key":"key-10.14336\/AD.2024.0328-75","doi-asserted-by":"crossref","unstructured":"Maloney B, Ray B, Hayden EP, Nurnberger JI Jr, Lahiri DK (2009). Development and validation of the high-quality \u2018rapid method for swab\u2019to genotype the HTTLPR serotonin transporter (SLC6A4) promoter polymorphism. Psychiatr Genet, 19: 72-82","DOI":"10.1097\/YPG.0b013e3283208091"},{"key":"key-10.14336\/AD.2024.0328-76","doi-asserted-by":"crossref","unstructured":"Maloney B, Lahiri DK (2016). Epigenetics of dementia: understanding the disease as a transformation rather than a state. Lancet Neurol, 15: 760-774","DOI":"10.1016\/S1474-4422(16)00065-X"},{"key":"key-10.14336\/AD.2024.0328-77","doi-asserted-by":"crossref","unstructured":"Hayden EP, Dougherty LR, Maloney B, Durbin CE, Olino TM, Nurnberger JI Jr, et al. (2007). Temperamental fearfulness in childhood and the serotonin transporter promoter region polymorphism: a multimethod association study. Psychiatr Genet, 17: 135-142","DOI":"10.1097\/YPG.0b013e3280147847"},{"key":"key-10.14336\/AD.2024.0328-78","doi-asserted-by":"crossref","unstructured":"Daubert EA, Condron BG (2010). Serotonin: a regulator of neuronal morphology and circuitry. Trends Neurosci, 33: 424-434","DOI":"10.1016\/j.tins.2010.05.005"},{"key":"key-10.14336\/AD.2024.0328-79","doi-asserted-by":"crossref","unstructured":"Kawai M, Rosen CJ (2010). Minireview: a skeleton in serotonin\u2019s closet? Endocrinology, 151: 4103-4108","DOI":"10.1210\/en.2010-0499"},{"key":"key-10.14336\/AD.2024.0328-80","doi-asserted-by":"crossref","unstructured":"Mattson MP, Maudsley S, Martin B (2004). A neural signaling triumvirate that influences ageing and age-related disease: insulin\/IGF-1, BDNF and serotonin. Ageing Res Rev, 3: 445-464","DOI":"10.1016\/j.arr.2004.08.001"},{"key":"key-10.14336\/AD.2024.0328-81","doi-asserted-by":"crossref","unstructured":"Murakami H, Bessinger K, Hellmann J, Murakami S (2008). Manipulation of serotonin signal suppresses early phase of behavioral aging in Caenorhabditis elegans. Neurobiol Aging, 29: 1093-1100","DOI":"10.1016\/j.neurobiolaging.2007.01.013"},{"key":"key-10.14336\/AD.2024.0328-82","doi-asserted-by":"crossref","unstructured":"Lu T, Pan Y, Kao S-Y, Li C, Kohane I, Chan J, et al. (2004). Gene regulation and DNA damage in the ageing human brain. Nature, 429: 883-891","DOI":"10.1038\/nature02661"},{"key":"key-10.14336\/AD.2024.0328-83","doi-asserted-by":"crossref","unstructured":"Rehman HU, Masson EA (2001). Neuroendocrinology of ageing. Age and ageing, 30: 279-287","DOI":"10.1093\/ageing\/30.4.279"},{"key":"key-10.14336\/AD.2024.0328-84","doi-asserted-by":"crossref","unstructured":"Wang H, Gao X-Y, Rao F, Yang H, Wang Z-Y, Liu L, et al. (2020). Mechanism of contractile dysfunction induced by serotonin in coronary artery in spontaneously hypertensive rats. Naunyn Schmiedebergs Arch Pharmacol, 393: 2165-2176","DOI":"10.1007\/s00210-020-01813-5"},{"key":"key-10.14336\/AD.2024.0328-85","doi-asserted-by":"crossref","unstructured":"Benninghoff J, Van Der Ven A, Schloesser RJ, Moessner R, M\u00f6ller HJ, Rujescu D (2012). The complex role of the serotonin transporter in adult neurogenesis and neuroplasticity. A critical review. World J Biol Psychiatry, 13: 240-247","DOI":"10.3109\/15622975.2011.640941"},{"key":"key-10.14336\/AD.2024.0328-86","doi-asserted-by":"crossref","unstructured":"Xu Y, Yan J, Zhou P, Li J, Gao H, Xia Y, et al. (2012). Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease. Prog Neurobiol, 97: 1-13","DOI":"10.1016\/j.pneurobio.2012.02.002"},{"key":"key-10.14336\/AD.2024.0328-87","doi-asserted-by":"crossref","unstructured":"van Dyck CH, Malison RT, Seibyl JP, Laruelle M, Klumpp H, Zoghbi SS, et al. (2000). Age-related decline in central serotonin transporter availability with [123I] \u03b2-CIT SPECT. Neurobiol Aging, 21: 497-501","DOI":"10.1016\/S0197-4580(00)00152-4"},{"key":"key-10.14336\/AD.2024.0328-88","doi-asserted-by":"crossref","unstructured":"Hesse S, Barthel H, Murai T, M\u00fcller U, M\u00fcller D, Seese A, et al. (2003). Is correction for age necessary in neuroimaging studies of the central serotonin transporter? Eur J Nucl Med Mol Imaging, 30: 427-430","DOI":"10.1007\/s00259-002-1044-6"},{"key":"key-10.14336\/AD.2024.0328-89","doi-asserted-by":"crossref","unstructured":"Kanova M, Kohout P (2021). Serotonin\u2014Its synthesis and roles in the healthy and the critically ill. Int J Mol Sci, 22: 4837","DOI":"10.3390\/ijms22094837"},{"key":"key-10.14336\/AD.2024.0328-90","doi-asserted-by":"crossref","unstructured":"Selim AM, Sarswat N, Kelesidis I, Iqbal M, Chandra R, Zolty R (2017). Plasma serotonin in heart failure: possible marker and potential treatment target. Heart Lung Circ, 26: 442-449","DOI":"10.1016\/j.hlc.2016.08.003"},{"key":"key-10.14336\/AD.2024.0328-91","doi-asserted-by":"crossref","unstructured":"Sheftel C. M., & Hernandez L. L. (2020). Serotonin stimulated parathyroid hormone related protein induction in the mammary epithelia by transglutaminase-dependent serotonylation. PLoS One, 15(10), e0241192","DOI":"10.1371\/journal.pone.0241192"},{"key":"key-10.14336\/AD.2024.0328-92","doi-asserted-by":"crossref","unstructured":"Bader M (2019). Serotonylation: serotonin signaling and epigenetics. Front Mol Neurosci, 12: 288","DOI":"10.3389\/fnmol.2019.00288"},{"key":"key-10.14336\/AD.2024.0328-93","doi-asserted-by":"crossref","unstructured":"Cooper A, Woulfe D, Kilic F (2019). Post-translational modifications of serotonin transporter. Pharmacol Res, 140: 7-13","DOI":"10.1016\/j.phrs.2018.10.018"},{"key":"key-10.14336\/AD.2024.0328-94","unstructured":"Muma NA (2018). Transglutaminase in receptor and neurotransmitter-regulated functions. Med One, 3"},{"key":"key-10.14336\/AD.2024.0328-95","doi-asserted-by":"crossref","unstructured":"Hummerich R, Costina V, Findeisen P, Schloss P (2015). Monoaminylation of fibrinogen and glia-derived proteins: indication for similar mechanisms in posttranslational protein modification in blood and brain. ACS Chem Neurosci, 6: 1130-1136","DOI":"10.1021\/cn5003286"},{"key":"key-10.14336\/AD.2024.0328-96","doi-asserted-by":"crossref","unstructured":"Watts SW, Priestley JR, Thompson JM (2009). Serotonylation of vascular proteins important to contraction. PLoS One, 4: e5682","DOI":"10.1371\/journal.pone.0005682"},{"key":"key-10.14336\/AD.2024.0328-97","doi-asserted-by":"crossref","unstructured":"Liu Y, Wei L, Laskin DL, Fanburg BL (2011). Role of protein transamidation in serotonin-induced proliferation and migration of pulmonary artery smooth muscle cells. Am J Respir Cell Mol Biol, 44: 548-555","DOI":"10.1165\/rcmb.2010-0078OC"},{"key":"key-10.14336\/AD.2024.0328-98","doi-asserted-by":"crossref","unstructured":"Wei L, Warburton RR, Preston IR, Roberts KE, Comhair SA, Erzurum SC, et al. (2012). Serotonylated fibronectin is elevated in pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol, 302: L1273-L1279","DOI":"10.1152\/ajplung.00082.2012"},{"key":"key-10.14336\/AD.2024.0328-99","doi-asserted-by":"crossref","unstructured":"Mi Z, Si T, Kapadia K, Li Q, Muma NA (2017). Receptor-stimulated transamidation induces activation of Rac1 and Cdc42 and the regulation of dendritic spines. Neuropharmacology, 117: 93-105","DOI":"10.1016\/j.neuropharm.2017.01.034"},{"key":"key-10.14336\/AD.2024.0328-100","doi-asserted-by":"crossref","unstructured":"Al-Zoairy R, Pedrini MT, Khan MI, Engl J, Tschoner A, Ebenbichler C, et al. (2017). Serotonin improves glucose metabolism by Serotonylation of the small GTPase Rab4 in L6 skeletal muscle cells. Diabetol Metab Syndr, 9: 1-9","DOI":"10.1186\/s13098-016-0201-1"},{"key":"key-10.14336\/AD.2024.0328-101","doi-asserted-by":"crossref","unstructured":"Bockaert J, B\u00e9camel C, Chaumont-Dubel S, Claeysen S, Vandermoere F, Marin P (2021). Novel and atypical pathways for serotonin signaling. Fac Rev, 10","DOI":"10.12703\/r\/10-52"},{"key":"key-10.14336\/AD.2024.0328-102","doi-asserted-by":"crossref","unstructured":"Wang H-M, Wang Y, Liu M, Bai Y, Zhang X-H, Sun Y-X, et al. (2012). Fluoxetine inhibits monocrotaline-induced pulmonary arterial remodeling involved in inhibition of RhoA-Rho kinase and Akt signalling pathways in rats. Can J Physiol Pharmacol, 90: 1506-1515","DOI":"10.1139\/y2012-108"},{"key":"key-10.14336\/AD.2024.0328-103","doi-asserted-by":"crossref","unstructured":"Redpath G, Deo N (2022). Serotonin: an overlooked regulator of endocytosis and endosomal sorting? Biol Open, 11: bio059057","DOI":"10.1242\/bio.059057"},{"key":"key-10.14336\/AD.2024.0328-104","doi-asserted-by":"crossref","unstructured":"Abdala-Valencia H, Berdnikovs S, McCary CA, Urick D, Mahadevia R, Marchese ME, et al. (2012). Inhibition of allergic inflammation by supplementation with 5-hydroxytryptophan. Am J Physiol Lung Cell Mol Physiol, 303: L642-L660","DOI":"10.1152\/ajplung.00406.2011"},{"key":"key-10.14336\/AD.2024.0328-105","doi-asserted-by":"crossref","unstructured":"Shajib M, Khan W (2015). The role of serotonin and its receptors in activation of immune responses and inflammation. Acta Physiol (Oxf), 213: 561-574","DOI":"10.1111\/apha.12430"},{"key":"key-10.14336\/AD.2024.0328-106","doi-asserted-by":"crossref","unstructured":"Sheftel CM, Hernandez LL (2020). Serotonin stimulated parathyroid hormone related protein induction in the mammary epithelia by transglutaminase-dependent serotonylation. PLoS One, 15: e0241192","DOI":"10.1371\/journal.pone.0241192"},{"key":"key-10.14336\/AD.2024.0328-107","doi-asserted-by":"crossref","unstructured":"Fulton SL, Mitra S, Lepack AE, Martin JA, Stewart AF, Converse J, et al. (2022). Histone H3 dopaminylation in ventral tegmental area underlies heroin-induced transcriptional and behavioral plasticity in male rats. Neuropsychopharmacology, 47: 1776-1783","DOI":"10.1038\/s41386-022-01279-4"},{"key":"key-10.14336\/AD.2024.0328-108","doi-asserted-by":"crossref","unstructured":"Dai Y, Dudek NL, Li Q, Muma NA (2011). Phospholipase C, Ca 2+, and calmodulin signaling are required for 5-HT 2A receptor-mediated transamidation of Rac1 by transglutaminase. Psychopharmacology (Berl), 213: 403-412","DOI":"10.1007\/s00213-010-1984-7"},{"key":"key-10.14336\/AD.2024.0328-109","doi-asserted-by":"crossref","unstructured":"Gapa L, Alfardus H, Fischle W (2022). Unconventional metabolites in chromatin regulation. Biosci Rep, 42: BSR20211558","DOI":"10.1042\/BSR20211558"},{"key":"key-10.14336\/AD.2024.0328-110","doi-asserted-by":"crossref","unstructured":"Ballestar E, Abad C, Franco L (1996). Core histones are glutaminyl substrates for tissue transglutaminase. J Biol Chem, 271: 18817-18824","DOI":"10.1074\/jbc.271.31.18817"},{"key":"key-10.14336\/AD.2024.0328-111","doi-asserted-by":"crossref","unstructured":"Lowery III CL, Elliott C, Cooper A, Hadden C, Sonon RN, Azadi P, et al. (2017). Cigarette smoking-associated alterations in serotonin\/adrenalin signaling pathways of platelets. J Am Heart Assoc, 6: e005465","DOI":"10.1161\/JAHA.116.005465"},{"key":"key-10.14336\/AD.2024.0328-112","doi-asserted-by":"crossref","unstructured":"Traxler L, Lagerwall J, Eichhorner S, Stefanoni D, D'Alessandro A, Mertens J (2021). Metabolism navigates neural cell fate in development, aging and neurodegeneration. Dis Model Mech, 14: dmm048993","DOI":"10.1242\/dmm.048993"},{"key":"key-10.14336\/AD.2024.0328-113","doi-asserted-by":"crossref","unstructured":"Zhao J, Chen W, Pan Y, Zhang Y, Sun H, Wang H, et al. (2021). Structural insights into the recognition of histone H3Q5 serotonylation by WDR5. Sci Adv, 7: eabf4291","DOI":"10.1126\/sciadv.abf4291"},{"key":"key-10.14336\/AD.2024.0328-114","doi-asserted-by":"crossref","unstructured":"Chan JC, Maze I (2020). Nothing is yet set in (hi) stone: novel post-translational modifications regulating chromatin function. Trends Biochem Sci, 45: 829-844","DOI":"10.1016\/j.tibs.2020.05.009"},{"key":"key-10.14336\/AD.2024.0328-115","doi-asserted-by":"crossref","unstructured":"Szasz R, Dale GL (2003). COAT platelets. Curr Opin Hematol, 10: 351-355","DOI":"10.1097\/00062752-200309000-00005"},{"key":"key-10.14336\/AD.2024.0328-116","doi-asserted-by":"crossref","unstructured":"Penumatsa K, Abualkhair S, Wei L, Warburton R, Preston I, Hill NS, et al. (2014). Tissue transglutaminase promotes serotonin-induced AKT signaling and mitogenesis in pulmonary vascular smooth muscle cells. Cell Signal, 26: 2818-2825","DOI":"10.1016\/j.cellsig.2014.09.002"},{"key":"key-10.14336\/AD.2024.0328-117","doi-asserted-by":"crossref","unstructured":"Cui C, Kaartinen MT (2015). Serotonin (5-HT) inhibits Factor XIII-A-mediated plasma fibronectin matrix assembly and crosslinking in osteoblast cultures via direct competition with transamidation. Bone, 72: 43-52","DOI":"10.1016\/j.bone.2014.11.008"},{"key":"key-10.14336\/AD.2024.0328-118","doi-asserted-by":"crossref","unstructured":"Martino A, Ettorre M, Musilli M, Lorenzetto E, Buffelli M, Diana G (2013). Rho GTPase-dependent plasticity of dendritic spines in the adult brain. Front Cell Neurosci, 7: 62","DOI":"10.3389\/fncel.2013.00062"},{"key":"key-10.14336\/AD.2024.0328-119","doi-asserted-by":"crossref","unstructured":"Shirakawa R, Yoshioka A, Horiuchi H, Nishioka H, Tabuchi A, Kita T (2000). Small GTPase Rab4 regulates Ca2+-induced \u03b1-granule secretion in platelets. J Biol Chem, 275: 33844-33849","DOI":"10.1074\/jbc.M002834200"},{"key":"key-10.14336\/AD.2024.0328-120","doi-asserted-by":"crossref","unstructured":"Schoenwaelder SM, Hughan SC, Boniface K, Fernando S, Holdsworth M, Thompson PE, et al. (2002). RhoA Sustains Integrin \u03b1IIb\u03b23Adhesion Contacts under High Shear. J Biol Chem, 277: 14738-14746","DOI":"10.1074\/jbc.M200661200"},{"key":"key-10.14336\/AD.2024.0328-121","doi-asserted-by":"crossref","unstructured":"Azim A, Barkalow K, Chou J, Hartwig J (2000). Activation of the small GTPases, rac and cdc42, after ligation of the platelet PAR-1 receptor. Blood, 95: 959-964","DOI":"10.1182\/blood.V95.3.959.003k22_959_964"},{"key":"key-10.14336\/AD.2024.0328-122","doi-asserted-by":"crossref","unstructured":"Dai Y, Dudek NL, Patel TB, Muma NA (2008). Transglutaminase-catalyzed transamidation: a novel mechanism for Rac1 activation by 5-hydroxytryptamine2A receptor stimulation. J Pharmacol Exp Ther, 326: 153-162","DOI":"10.1124\/jpet.107.135046"},{"key":"key-10.14336\/AD.2024.0328-123","doi-asserted-by":"crossref","unstructured":"Kouzarides T (2007). Chromatin modifications and their function. Cell, 128: 693-705","DOI":"10.1016\/j.cell.2007.02.005"},{"key":"key-10.14336\/AD.2024.0328-124","doi-asserted-by":"crossref","unstructured":"Ruthenburg AJ, Li H, Patel DJ, David Allis C (2007). Multivalent engagement of chromatin modifications by linked binding modules. Nat Rev Mol Cell Biol, 8: 983-994","DOI":"10.1038\/nrm2298"},{"key":"key-10.14336\/AD.2024.0328-125","doi-asserted-by":"crossref","unstructured":"Patel DJ (2016). A structural perspective on readout of epigenetic histone and DNA methylation marks. Cold Spring Harb Perspect Biol, 8: a018754","DOI":"10.1101\/cshperspect.a018754"},{"key":"key-10.14336\/AD.2024.0328-126","doi-asserted-by":"crossref","unstructured":"Torres IO, Fujimori DG (2015). Functional coupling between writers, erasers and readers of histone and DNA methylation. Curr Opin Struct Biol, 35: 68-75","DOI":"10.1016\/j.sbi.2015.09.007"},{"key":"key-10.14336\/AD.2024.0328-127","doi-asserted-by":"crossref","unstructured":"Jenuwein T, Allis CD (2001). Translating the histone code. Science, 293: 1074-1080","DOI":"10.1126\/science.1063127"},{"key":"key-10.14336\/AD.2024.0328-128","doi-asserted-by":"crossref","unstructured":"Allis CD, Jenuwein T (2016). The molecular hallmarks of epigenetic control. Nat Rev Genet, 17: 487-500","DOI":"10.1038\/nrg.2016.59"},{"key":"key-10.14336\/AD.2024.0328-129","doi-asserted-by":"crossref","unstructured":"Chi P, Allis CD, Wang GG (2010). Covalent histone modifications\u2014miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer, 10: 457-469","DOI":"10.1038\/nrc2876"},{"key":"key-10.14336\/AD.2024.0328-130","doi-asserted-by":"crossref","unstructured":"Venkatesh S, Workman JL (2015). Histone exchange, chromatin structure and the regulation of transcription. Nat Rev Mol Cell Biol, 16: 178-189","DOI":"10.1038\/nrm3941"},{"key":"key-10.14336\/AD.2024.0328-131","doi-asserted-by":"crossref","unstructured":"Kim H-J, Lee J-H, Cho S-Y, Jeon J-H, Kim I-G (2021). Transglutaminase 2 mediates transcriptional regulation through BAF250a polyamination. Genes & Genomics, 43: 333-342","DOI":"10.1007\/s13258-021-01055-6"},{"key":"key-10.14336\/AD.2024.0328-132","doi-asserted-by":"crossref","unstructured":"Zhao S, Chuh KN, Zhang B, Dul BE, Thompson RE, Farrelly LA, et al. (2021). Histone H3Q5 serotonylation stabilizes H3K4 methylation and potentiates its readout. Proc Natl Acad Sci, 118: e2016742118","DOI":"10.1073\/pnas.2016742118"},{"key":"key-10.14336\/AD.2024.0328-133","doi-asserted-by":"crossref","unstructured":"Nguyen UT, Bittova L, M\u00fcller MM, Fierz B, David Y, Houck-Loomis B, et al. (2014). Accelerated chromatin biochemistry using DNA-barcoded nucleosome libraries. Nat Methods, 11: 834-840","DOI":"10.1038\/nmeth.3022"},{"key":"key-10.14336\/AD.2024.0328-134","doi-asserted-by":"crossref","unstructured":"Simon MD, Shokat KM. 2012. A method to site-specifically incorporate methyl-lysine analogues into recombinant proteins. Methods Enzymol, Vol. 512 pp. 57-69, Elsevier","DOI":"10.1016\/B978-0-12-391940-3.00003-2"},{"key":"key-10.14336\/AD.2024.0328-135","doi-asserted-by":"crossref","unstructured":"Fierz B, Chatterjee C, McGinty RK, Bar-Dagan M, Raleigh DP, Muir TW (2011). Histone H2B ubiquitylation disrupts local and higher-order chromatin compaction. Nat Chem Biol, 7: 113-119","DOI":"10.1038\/nchembio.501"},{"key":"key-10.14336\/AD.2024.0328-136","doi-asserted-by":"crossref","unstructured":"Zhang S-M, Cai WL, Liu X, Thakral D, Luo J, Chan LH, et al. (2021). KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements. Nature, 598: 682-687","DOI":"10.1038\/s41586-021-03994-2"},{"key":"key-10.14336\/AD.2024.0328-137","doi-asserted-by":"crossref","unstructured":"Johnson KB, Thompson JM, Watts SW (2010). Modification of proteins by norepinephrine is important for vascular contraction. Front Physiol, 1: 131","DOI":"10.3389\/fphys.2010.00131"},{"key":"key-10.14336\/AD.2024.0328-138","doi-asserted-by":"crossref","unstructured":"Lin JC-Y, Chou C-C, Tu Z, Yeh L-F, Wu S-C, Khoo K-H, et al. (2014). Characterization of protein serotonylation via bioorthogonal labeling and enrichment. J Proteome Res, 13: 3523-3529","DOI":"10.1021\/pr5003438"},{"key":"key-10.14336\/AD.2024.0328-139","doi-asserted-by":"crossref","unstructured":"Harada K, Sho R, Takakura H, Yokoyama E, Koyama R, Yamamoto Y, et al. (2023). S-Palmitoylation of the serotonin transporter promotes its cell surface expression and serotonin uptake. Biochem Biophys Res Commun, 662: 58-65","DOI":"10.1016\/j.bbrc.2023.04.028"},{"key":"key-10.14336\/AD.2024.0328-140","doi-asserted-by":"crossref","unstructured":"Rudnick G, Clark J (1993). From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters. Biochim Biophys Acta, 1144: 249-263","DOI":"10.1016\/0005-2728(93)90109-S"},{"key":"key-10.14336\/AD.2024.0328-141","doi-asserted-by":"crossref","unstructured":"Chen J-G, Liu-Chen S, Rudnick G (1997). External cysteine residues in the serotonin transporter. Biochemistry, 36: 1479-1486","DOI":"10.1021\/bi962256g"},{"key":"key-10.14336\/AD.2024.0328-142","doi-asserted-by":"crossref","unstructured":"Ramamoorthy S, Cool DR, Mahesh VB, Leibach FH, Melikian HE, Blakely RD, (1993). Regulation of the human serotonin transporter. Cholera toxin-induced stimulation of serotonin uptake in human placental choriocarcinoma cells is accompanied by increased serotonin transporter mRNA levels and serotonin transporter-specific ligand binding. J Biol Chem, 268(29), 21626-21631","DOI":"10.1016\/S0021-9258(20)80587-0"},{"key":"key-10.14336\/AD.2024.0328-143","doi-asserted-by":"crossref","unstructured":"Ramamoorthy S, Cool D, Mahesh V, Leibach F, Melikian H, Blakely R, et al. (1993). Regulation of the human serotonin transporter. Cholera toxin-induced stimulation of serotonin uptake in human placental choriocarcinoma cells is accompanied by increased serotonin transporter mRNA levels and serotonin transporter-specific ligand binding. J Biol Chem, 268: 21626-21631","DOI":"10.1016\/S0021-9258(20)80587-0"},{"key":"key-10.14336\/AD.2024.0328-144","doi-asserted-by":"crossref","unstructured":"Cool DR, Leibach FH, Ganapathy V (1990). Modulation of serotonin uptake kinetics by ions and ion gradients in human placental brush-border membrane vesicles. Biochemistry, 29: 1818-1822","DOI":"10.1021\/bi00459a022"},{"key":"key-10.14336\/AD.2024.0328-145","doi-asserted-by":"crossref","unstructured":"Baudry A, Pietri M, Launay J-M, Kellermann O, Schneider B (2019). Multifaceted regulations of the serotonin transporter: impact on antidepressant response. Front Neurosci, 13: 91","DOI":"10.3389\/fnins.2019.00091"},{"key":"key-10.14336\/AD.2024.0328-146","doi-asserted-by":"crossref","unstructured":"Ellgaard L, Molinari M, Helenius A (1999). Setting the standards: quality control in the secretory pathway. Science, 286: 1882-1888","DOI":"10.1126\/science.286.5446.1882"},{"key":"key-10.14336\/AD.2024.0328-147","doi-asserted-by":"crossref","unstructured":"Jansen M, Beaumelle B (2022). How palmitoylation affects trafficking and signaling of membrane receptors. Biol Cell, 114: 61-72","DOI":"10.1111\/boc.202100052"},{"key":"key-10.14336\/AD.2024.0328-148","doi-asserted-by":"crossref","unstructured":"Rawat P, Sehar U, Bisht J, Selman A, Culberson J, Reddy PH (2022). Phosphorylated tau in Alzheimer\u2019s disease and other tauopathies. Int J Mol Sci, 23: 12841","DOI":"10.3390\/ijms232112841"},{"key":"key-10.14336\/AD.2024.0328-149","doi-asserted-by":"crossref","unstructured":"Sehar U, Rawat P, Reddy AP, Kopel J, Reddy PH (2022). Amyloid beta in aging and Alzheimer\u2019s disease. I Int J Mol Sci, 23: 12924","DOI":"10.3390\/ijms232112924"},{"key":"key-10.14336\/AD.2024.0328-150","doi-asserted-by":"crossref","unstructured":"Reddy AP, Yin X, Sawant N, Reddy PH (2021). Protective effects of antidepressant citalopram against abnormal APP processing and amyloid beta-induced mitochondrial dynamics, biogenesis, mitophagy and synaptic toxicities in Alzheimer\u2019s disease. Hum Mol Genet, 30: 847-864","DOI":"10.1093\/hmg\/ddab054"},{"key":"key-10.14336\/AD.2024.0328-151","doi-asserted-by":"crossref","unstructured":"Green RC, Cupples LA, Kurz A, Auerbach S, Go R, Sadovnick D, et al. (2003). Depression as a risk factor for Alzheimer disease: the MIRAGE Study. Arch Neurol, 60: 753-759","DOI":"10.1001\/archneur.60.5.753"},{"key":"key-10.14336\/AD.2024.0328-152","doi-asserted-by":"crossref","unstructured":"Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D (2006). Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry, 63: 530-538","DOI":"10.1001\/archpsyc.63.5.530"},{"key":"key-10.14336\/AD.2024.0328-153","doi-asserted-by":"crossref","unstructured":"Rapp MA, Schnaider-Beeri M, Grossman HT, Sano M, Perl DP, Purohit DP, et al. (2006). Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. Arch Gen Psychiatry, 63: 161-167","DOI":"10.1001\/archpsyc.63.2.161"},{"key":"key-10.14336\/AD.2024.0328-154","doi-asserted-by":"crossref","unstructured":"Rapp MA, Schnaider-Beeri M, Purohit DP, Perl DP, Haroutunian V, Sano M (2008). Increased neurofibrillary tangles in patients with Alzheimer disease with comorbid depression. Am J Geriatr Psychiatry, 16: 168-174","DOI":"10.1097\/JGP.0b013e31816029ec"},{"key":"key-10.14336\/AD.2024.0328-155","doi-asserted-by":"crossref","unstructured":"Muma NA, Kapadia K. 2020. Serotonylation and neuronal function. In Handbook of Behavioral Neuroscience, Vol. 31 pp. 257-265, Elsevier","DOI":"10.1016\/B978-0-444-64125-0.00013-X"},{"key":"key-10.14336\/AD.2024.0328-156","doi-asserted-by":"crossref","unstructured":"Pandya CD, Hoda N, Crider A, Peter D, Kutiyanawalla A, Kumar S, et al. (2017), Transglutaminase 2 overexpression induces depressive-like behavior and impaired TrkB signaling in mice. Mol Psychiatry, 22: 745-753","DOI":"10.1038\/mp.2016.145"},{"key":"key-10.14336\/AD.2024.0328-157","doi-asserted-by":"crossref","unstructured":"Muma NA (2007). Transglutaminase is linked to neurodegenerative diseases. J J Neuropathol Exp Neurol, 66: 258-263","DOI":"10.1097\/nen.0b013e31803d3b02"},{"key":"key-10.14336\/AD.2024.0328-158","doi-asserted-by":"crossref","unstructured":"Appelt DM, Kopen GC, Boyne LJ, Balin BJ (1996). Localization of transglutaminase in hippocampal neurons: implications for Alzheimer's disease. J Histochem Cytochem, 44: 1421-1427","DOI":"10.1177\/44.12.8985134"},{"key":"key-10.14336\/AD.2024.0328-159","doi-asserted-by":"crossref","unstructured":"Citron BA, Suo Z, SantaCruz K, Davies PJ, Qin F, Festoff BW (2002). Protein crosslinking, tissue transglutaminase, alternative splicing and neurodegeneration. Neurochem Int, 40: 69-78","DOI":"10.1016\/S0197-0186(01)00062-6"},{"key":"key-10.14336\/AD.2024.0328-160","doi-asserted-by":"crossref","unstructured":"Singer SM, Zainelli GM, Norlund MA, Lee JM, Muma NA (2002). Transglutaminase bonds in neurofibrillary tangles and paired helical filament tau early in Alzheimer's disease. Neurochem Int, 40: 17-30","DOI":"10.1016\/S0197-0186(01)00061-4"},{"key":"key-10.14336\/AD.2024.0328-161","doi-asserted-by":"crossref","unstructured":"Zemaitaitis MO, Lee JM, Troncoso JC, Muma NA (2000). Transglutaminase-induced cross-linking of tau proteins in progressive supranuclear palsy. J Neuropathol Exp Neurol, 59: 983-989","DOI":"10.1093\/jnen\/59.11.983"},{"key":"key-10.14336\/AD.2024.0328-162","doi-asserted-by":"crossref","unstructured":"Hartley DM, Zhao C, Speier AC, Woodard GA, Li S, Li Z, et al. (2008). Transglutaminase induces protofibril-like amyloid \u03b2-protein assemblies that are protease-resistant and inhibit long-term potentiation. J Biol Chem, 283: 16790-16800","DOI":"10.1074\/jbc.M802215200"},{"key":"key-10.14336\/AD.2024.0328-163","doi-asserted-by":"crossref","unstructured":"Schmid AW, Chiappe D, Pignat V, Grimminger V, Hang I, Moniatte M, et al. (2009). Dissecting the mechanisms of tissue transglutaminase-induced cross-linking of \u03b1-synuclein: implications for the pathogenesis of Parkinson disease. J Biol Chem, 284: 13128-13142","DOI":"10.1074\/jbc.M809067200"},{"key":"key-10.14336\/AD.2024.0328-164","doi-asserted-by":"crossref","unstructured":"Nemes Z, Petrovski G, Aerts M, Sergeant K, Devreese B, F\u00e9s\u00fcs L (2009). Transglutaminase-mediated intramolecular cross-linking of membrane-bound \u03b1-synuclein promotes amyloid formation in Lewy bodies. J Biol Chem, 284: 27252-27264","DOI":"10.1074\/jbc.M109.033969"},{"key":"key-10.14336\/AD.2024.0328-165","doi-asserted-by":"crossref","unstructured":"Bowen D, Allen S, Benton J, Goodhardt M, Haan E, Palmer A, et al. (1983). Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease. J Neurochem, 41: 266-272","DOI":"10.1111\/j.1471-4159.1983.tb11838.x"},{"key":"key-10.14336\/AD.2024.0328-166","doi-asserted-by":"crossref","unstructured":"Adolfsson R, Gottfries C, Roos B, Winblad B (1979). Changes in the brain catecholamines in patients with dementia of Alzheimer type. Br J Psychiatry, 135: 216-223","DOI":"10.1192\/bjp.135.3.216"},{"key":"key-10.14336\/AD.2024.0328-167","doi-asserted-by":"crossref","unstructured":"Nazarali AJ, Reynolds GP (1992). Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmortem study. Cell Mol Neurobiol, 12: 581-587","DOI":"10.1007\/BF00711237"},{"key":"key-10.14336\/AD.2024.0328-168","doi-asserted-by":"crossref","unstructured":"Mann D, Yates P (1983). Serotonin nerve cells in Alzheimer's disease. J Neurol Neurosurg Psychiatry, 46: 96","DOI":"10.1136\/jnnp.46.1.96"},{"key":"key-10.14336\/AD.2024.0328-169","doi-asserted-by":"crossref","unstructured":"Yamamoto T, Hirano A (1985). Nucleus raphe dorsalis in Alzheimer's disease: neurofibrillary tangles and loss of large neurons. Ann Neurol, 17: 573-577","DOI":"10.1002\/ana.410170608"},{"key":"key-10.14336\/AD.2024.0328-170","doi-asserted-by":"crossref","unstructured":"Hoogendijk WJ, Feenstra MG, Botterblom MH, Gilhuis J, Sommer IE, Kamphorst W, et al. (1999). Increased activity of surviving locus ceruleus neurons in Alzheimer's disease. Ann Neurol, 45: 82-91","DOI":"10.1002\/1531-8249(199901)45:1<82::AID-ART14>3.0.CO;2-T"},{"key":"key-10.14336\/AD.2024.0328-171","doi-asserted-by":"crossref","unstructured":"Chen CPH, Alder JT, Bowen DM, Esiri MM, McDonald B, Hope T, et al. (1996). Presynaptic serotonergic markers in community-acquired cases of Alzheimer's disease: correlations with depression and neuroleptic medication. J Neurochem, 66: 1592-1598","DOI":"10.1046\/j.1471-4159.1996.66041592.x"},{"key":"key-10.14336\/AD.2024.0328-172","doi-asserted-by":"crossref","unstructured":"Palmer A, Francis P, Benton J, Sims N, Mann D, Neary D, et al. (1987). Presynaptic serotonergic dysfunction in patients with Alzheimer's disease. J Neurochem, 48: 8-15","DOI":"10.1111\/j.1471-4159.1987.tb13120.x"},{"key":"key-10.14336\/AD.2024.0328-173","doi-asserted-by":"crossref","unstructured":"Garcia-Alloza M, Gil-Bea FJ, Diez-Ariza M, Chen C-H, Francis PT, Lasheras B, et al. (2005). Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer\u2019s disease. Neuropsychologia, 43: 442-449","DOI":"10.1016\/j.neuropsychologia.2004.06.007"},{"key":"key-10.14336\/AD.2024.0328-174","doi-asserted-by":"crossref","unstructured":"Tohgi H, Abe T, Takahashi S, Kimura M, Takahashi J, Kikuchi T (1992). Concentrations of serotonin and its related substances in the cerebrospinal fluid in patients with Alzheimer type dementia. Neurosci Lett, 141: 9-12","DOI":"10.1016\/0304-3940(92)90322-X"},{"key":"key-10.14336\/AD.2024.0328-175","doi-asserted-by":"crossref","unstructured":"Tohgi H, Abe T, Takahashi S, Saheki M, Kimura M (1995). Indoleamine concentrations in cerebrospinal fluid from patients with Alzheimer type and Binswanger type dementias before and after administration of citalopram, a synthetic serotonin uptake inhibitor. J Neural Transm Park Dis Dement Sect, 9: 121-131","DOI":"10.1007\/BF02259654"},{"key":"key-10.14336\/AD.2024.0328-176","unstructured":"van Praag H. 1994. Current Therapeutic Approaches to Panic and Other Anxiety Disorders. Karger Basel"},{"key":"key-10.14336\/AD.2024.0328-177","doi-asserted-by":"crossref","unstructured":"Brewerton TD (1995). Toward a unified theory of serotonin dysregulation in eating and related disorders. Psychoneuroendocrinology, 20: 561-590","DOI":"10.1016\/0306-4530(95)00001-5"},{"key":"key-10.14336\/AD.2024.0328-178","doi-asserted-by":"crossref","unstructured":"Young SN, Gauthier S, Anderson GM, Purdy WC (1980). Tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human cerebrospinal fluid: interrelationships and the influence of age, sex, epilepsy and anticonvulsant drugs. J Neurol Neurosurg Psychiatry, 43: 438-445","DOI":"10.1136\/jnnp.43.5.438"},{"key":"key-10.14336\/AD.2024.0328-179","doi-asserted-by":"crossref","unstructured":"Mefford IN, Rudorfer MV, Linnoila M, Potter WZ (1986). Interacting neurotransmitter systems. A non-experimental approach to the 5HIAA-HVA correlation in human CSF. J Psychiatr Res, 20: 175-193","DOI":"10.1016\/0022-3956(86)90002-6"},{"key":"key-10.14336\/AD.2024.0328-180","doi-asserted-by":"crossref","unstructured":"Weissman MM, Olfson M (1995). Depression in women: implications for health care research. Science, 269: 799-801","DOI":"10.1126\/science.7638596"},{"key":"key-10.14336\/AD.2024.0328-181","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez JJ, Noristani HN, Verkhratsky A (2012). The serotonergic system in ageing and Alzheimer's disease. Prog Neurobiol, 99: 15-41","DOI":"10.1016\/j.pneurobio.2012.06.010"},{"key":"key-10.14336\/AD.2024.0328-182","doi-asserted-by":"crossref","unstructured":"Chen CH, Eastwood S, Hope T, McDonald B, Francis P, Esiri M (2000). Immunocytochemical study of the dorsal and median raphe nuclei in patients with Alzheimer\u2019s disease prospectively assessed for behavioural changes. Neuropathol Appl Neurobiol, 26: 347-355","DOI":"10.1046\/j.1365-2990.2000.00254.x"},{"key":"key-10.14336\/AD.2024.0328-183","doi-asserted-by":"crossref","unstructured":"Lai MK, Tsang SW, Francis PT, Keene J, Hope T, Esiri MM, et al. (2002). Postmortem serotoninergic correlates of cognitive decline in Alzheimer's disease. Neuroreport, 13: 1175-1178","DOI":"10.1097\/00001756-200207020-00021"},{"key":"key-10.14336\/AD.2024.0328-184","doi-asserted-by":"crossref","unstructured":"Eckert RL, Fisher ML, Grun D, Adhikary G, Xu W, Kerr C (2015). Transglutaminase is a tumor cell and cancer stem cell survival factor. Mol Carcinog, 54: 947-958","DOI":"10.1002\/mc.22375"},{"key":"key-10.14336\/AD.2024.0328-185","doi-asserted-by":"crossref","unstructured":"Liu C, Kellems RE, Xia Y (2017). Inflammation, autoimmunity, and hypertension: the essential role of tissue transglutaminase. Am J Hypertens, 30: 756-764","DOI":"10.1093\/ajh\/hpx027"},{"key":"key-10.14336\/AD.2024.0328-186","doi-asserted-by":"crossref","unstructured":"Shinde AV, Frangogiannis NG (2018). Tissue transglutaminase in the pathogenesis of heart failure. Cell Death Differ, 25: 453","DOI":"10.1038\/s41418-017-0028-9"},{"key":"key-10.14336\/AD.2024.0328-187","doi-asserted-by":"crossref","unstructured":"Martucciello S, Paolella G, Esposito C, Lepretti M, Caputo I (2018). Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease. Cell Mol Life Sci, 75: 4107-4124","DOI":"10.1007\/s00018-018-2902-0"},{"key":"key-10.14336\/AD.2024.0328-188","doi-asserted-by":"crossref","unstructured":"Kim GE, Park HH (2020). Structures of human transglutaminase 2: finding clues for interference in cross-linking mediated activity. Int J Mol Sci, 21: 2225","DOI":"10.3390\/ijms21062225"},{"key":"key-10.14336\/AD.2024.0328-189","doi-asserted-by":"crossref","unstructured":"Zhuang R, Khosla C (2020). Substrates, inhibitors, and probes of mammalian transglutaminase 2. Anal Biochem, 591: 113560","DOI":"10.1016\/j.ab.2019.113560"},{"key":"key-10.14336\/AD.2024.0328-190","doi-asserted-by":"crossref","unstructured":"Song M, Hwang H, Im CY, Kim S-Y (2017). Recent Progress in the Development of Transglutaminase 2 (TGase2) Inhibitors: Miniperspective. J Med Chem, 60: 554-567","DOI":"10.1021\/acs.jmedchem.6b01036"},{"key":"key-10.14336\/AD.2024.0328-191","doi-asserted-by":"crossref","unstructured":"Kshirsagar S, Sawant N, Morton H, Reddy AP, Reddy PH (2021). Mitophagy enhancers against phosphorylated Tau-induced mitochondrial and synaptic toxicities in Alzheimer disease. Pharmacol Res, 174: 105973","DOI":"10.1016\/j.phrs.2021.105973"},{"key":"key-10.14336\/AD.2024.0328-192","doi-asserted-by":"crossref","unstructured":"Reddy AP, Sawant N, Morton H, Kshirsagar S, Bunquin LE, Yin X, et al. (2021). Selective serotonin reuptake inhibitor citalopram ameliorates cognitive decline and protects against amyloid beta-induced mitochondrial dynamics, biogenesis, autophagy, mitophagy and synaptic toxicities in a mouse model of Alzheimer\u2019s disease. Hum Mol Genet, 30: 789-810","DOI":"10.1093\/hmg\/ddab091"},{"key":"key-10.14336\/AD.2024.0328-193","unstructured":"Meyer JH (2007). Imaging the serotonin transporter during major depressive disorder and antidepressant treatment: 2005 CCNP Young Investigator Award Paper. J Psychiatry Neurosci, 32: 86-102"},{"key":"key-10.14336\/AD.2024.0328-194","doi-asserted-by":"crossref","unstructured":"Bacq A, Balasse L, Biala G, Guiard B, Gardier A, Schinkel A, et al. (2012). Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response. Mol Psychiatry, 17: 926-939","DOI":"10.1038\/mp.2011.87"},{"key":"key-10.14336\/AD.2024.0328-195","doi-asserted-by":"crossref","unstructured":"Monta\u00f1ez S, Daws LC, Gould GG, Frazer A (2003). Serotonin (5-HT) transporter (SERT) function after graded destruction of serotonergic neurons. J Neurochem, 87: 861-867","DOI":"10.1046\/j.1471-4159.2003.02032.x"},{"key":"key-10.14336\/AD.2024.0328-196","doi-asserted-by":"crossref","unstructured":"De Ponti F (2004). Pharmacology of serotonin: what a clinician should know. Gut, 53: 1520-1535","DOI":"10.1136\/gut.2003.035568"},{"key":"key-10.14336\/AD.2024.0328-197","doi-asserted-by":"crossref","unstructured":"Matthes S, Bader M (2018). Peripheral serotonin synthesis as a new drug target. Trends Pharmacol Sci, 39: 560-572","DOI":"10.1016\/j.tips.2018.03.004"}],"container-title":["Aging and disease"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T12:21:43Z","timestamp":1743769303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aginganddisease.org\/EN\/10.14336\/AD.2024.0328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":197,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.14336\/ad.2024.0328","relation":{},"ISSN":["2152-5250"],"issn-type":[{"value":"2152-5250","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}